Not everyone in MO teams will fit the next phase. That’s not a failure. The role itself has fundamentally changed

Designing systems where the right prescribing decision is the easiest one to make is now essential, not optional.

What are the big and difficult decisions we in the medicines leadership world are going to have to make in the next 12 months, and how can we make them well?

Turning good analysis into decisions, not just discussions.

And how perspective, rather than imitation, brings clarity

Care based around a local population sounds like a no brainer. That's the problem.

For clarity in complexity

Honest lessons, oversharing disasters, and why it’s not just selling yourself

The NHS keeps promising world-leading access to innovation while removing the tools needed to deliver it, and failing to understand why it fails

A deep dive into the latest guidance

From Blockbuster to Bank-Buster: The 'King Kong of Fat Jabs' price rise and what it tells us about the politics of drug pricing

The Illusion of Control in Managing Prescribing Budgets